The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial
Open accessAbstract
Summary: Corticosteroids are an essential component of treatment for acute lymphoblastic leukaemia (ALL). Prednisolone is the most commonly used steroid, particularly in the maintenance phase of therapy. There is increasing evidence that, even in equipotent dosage for glucocorticoid effect, dexamethasone has enhanced lymphoblast cytotoxicity and penetration of the central nervous system (CNS) compared with prednisolone. Substitution of dexamethasone for prednisolone in the treatment of ALL might, therefore, result in improved event‐free and overall survival. Children with newly diagnosed ALL were randomly assigned to receive either dexamethasone or prednisolone in the induction, consolidation (all received dexamethasone in intensification) and continuation phases of treatment. Among 1603 eligible randomized patients, those receiving dexamethasone had half the risk of isolated CNS relapse (P = 0·0007). Event‐free survival was significantly improved with dexamethasone (84·2% vs. 75·6% at 5 years; P = 0·01), with no evidence of differing effects in any subgroup of patients. The use of 6·5 mg/m 2 dexamethasone throughout treatment for ALL led to a significant decrease in the risk of relapse for all risk‐groups of patients and, despite the increased toxicity, should now be regarded as part of standard therapy for childhood ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Antiplatelet Trialists' Collaboration (1988) · BMJ · doi:10.1136/bmj.296.6618.320 · Cited by 1,047
Silverman, L. B. (2001) · Blood · doi:10.1182/blood.v97.5.1211 · Cited by 865
Balis, F. M., Lester, C. M., Chrousos, G. P., Heideman, R. L., & Poplack, D. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.2.202 · Cited by 251
Akslen, L. A., & LiVolsi, V. A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000415)88:8<1964::aid-cncr27>3.0.co;2-1 · Cited by 231
Veerman, A. J., Hählen, K., Kamps, W. A., Van Leeuwen, E. F., De Vaan, G. A., Solbu, G., Suciu, S., Van Wering, E. R., & Van der Does-Van der Berg, A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.911 · Cited by 204
Mitchell, C., Richards, S., Harrison, C. J., & Eden, T. (2010) · Leukemia · doi:10.1038/leu.2009.256 · Cited by 198
Self-citationJones, B., Freeman, A. I., Shuster, J. J., Jacquillat, C., Weil, M., Pochedly, C., Sinks, L. F., Chevalier, L., Maurer, H. M., Koch, K., et al. (1991) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950190411 · Cited by 150
Eden, O. B., Harrison, G., Richards, S. M., Lilleyman, J., Bailey, C., Chessells, J. M., Hann, I. M., Hill, F. G. H., & Gibson, B. E. S. (2000) · Leukemia · doi:10.1038/sj.leu.2401962 · Cited by 117
Self-citation
Cited by
Current concepts in the diagnosis and management of cytokine release syndrome.
Lee, D. W., Gardner, R., Porter, D. L., Louis, C. U., Ahmed, N., Jensen, M., Grupp, S. A., & Mackall, C. L. (2014) · Blood · doi:10.1182/blood-2014-05-552729 · Cited by 2,806
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Pui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Metadata
- Authors
- Mitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., Eden, T. O. B., & the Medical Research Council Childhood Leukaemia Working Party
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 129
- Issue
- 6
- Pages
- 734-745
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2014561096
- Cited by
- 418
- References
- 13
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05509.x
- The paper
- Mitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., Eden, T. O. B., & the Medical Research Council Childhood Leukaemia Working Party. (2005). Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05509.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.